Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

about

The Potential of Nanotechnology in Medically Assisted Reproduction.

P2860

Q47708723-9C1B9CF5-FD65-4D41-A6F4-41B4B245C966

P2860

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

Item

http://www.wikidata.org/entity/Q45869832

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

@en

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

@nl

type

Item

label

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

@en

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

@nl

prefLabel

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

@en

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

@nl

P1476

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

@en

P2093

Alan D Salama

http://www.w3.org/2001/XMLSchema#string

Cecile Duret

http://www.w3.org/2001/XMLSchema#string

Christine Rivat

http://www.w3.org/2001/XMLSchema#string

Frances Male

http://www.w3.org/2001/XMLSchema#string

Frederick D Bushman

http://www.w3.org/2001/XMLSchema#string

H Bobby Gaspar

http://www.w3.org/2001/XMLSchema#string

Havinder Hara

http://www.w3.org/2001/XMLSchema#string

Hazem Ibrahim

http://www.w3.org/2001/XMLSchema#string

Karen Buckland

http://www.w3.org/2001/XMLSchema#string

Katie Butler

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Selection of target sites for mobile DNA integration in the human genome

The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages.

Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment.

Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Current and emerging treatment options for Wiskott-Aldrich syndrome.

The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.

Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.

P304

1327-1335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-04-777136

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28716862

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5813727

http://www.w3.org/2001/XMLSchema#string

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

about

P2860

P2860

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932